Dorsey Wright & Associates’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$14.8M Sell
62,128
-51,026
-45% -$10.6M 2.5% 6
2026
Q1
$23.9M Buy
113,154
+84,997
+302% +$18.3M 2.96% 5
2025
Q4
$6.03M Sell
28,157
-1,161
-4% -$218K 1.3% 22
2025
Q3
$4.6M Buy
29,318
+28,130
+2,368% +$4.35M 1.03% 32
2025
Q2
$200K Buy
+1,188
New +$176K 0.05% 132
2024
Q2
Sell
-15,001
Closed -$1.68M 124
2024
Q1
$1.68M Buy
15,001
+12,014
+402% +$1.3M 0.44% 98
2023
Q4
$301K Sell
2,987
-13
-0.4% -$1.29K 0.09% 115
2023
Q3
$260K Buy
+3,000
New +$271K 0.08% 118

Other funds holding CAH

Dorsey Wright & Associates's CAH Position: Q2 2026 in Review

Dorsey Wright & Associates reduced its Cardinal Health (CAH) stake by 45% in Q2 2026, selling an estimated $10.6M and leaving 62,128 shares worth $14.8M. The position accounts for 2.5% of the portfolio, ranked #6.

Dorsey Wright & Associates first reported a position in CAH in Q3 2023 and has held it in 8 quarters since. The position peaked at $23.9M in Q1 2026. 1,490 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Dorsey Wright & Associates held 62,128 shares of Cardinal Health worth $14.8M as of Q2 2026.
  • Dorsey Wright & Associates sold 51,026 Cardinal Health shares in Q2 2026, an estimated $10.6M.
  • Cardinal Health made up 2.5% of Dorsey Wright & Associates's portfolio in Q2 2026, its #6 holding.
  • Dorsey Wright & Associates first reported a position in Cardinal Health in Q3 2023 and has held it in 8 quarters since.
  • Dorsey Wright & Associates's Cardinal Health position peaked at $23.9M in Q1 2026.
  • 1,490 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Dorsey Wright & Associates's 13F filing for Q2 2026, filed 6 Aug 2026.